AMAG Pharma (AMAG) Reports Q1 Loss of $0.72/sh

May 11, 2020 7:09 AM EDT

AMAG Pharma (NASDAQ: AMAG) reported Q1 EPS of ($0.72), versus ($3.54) reported last year. Revenue for the quarter came in at $68.7 million versus the consensus estimate of $64.82 million.

For earnings history and earnings-related data on AMAG Pharma (AMAG) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings